Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Palsy | 2 | 2024 | 107 | 0.740 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2024 | 28 | 0.430 |
Why?
|
| Nervous System Malformations | 1 | 2024 | 42 | 0.420 |
Why?
|
| Dystonia | 1 | 2024 | 25 | 0.420 |
Why?
|
| Dystonic Disorders | 1 | 2024 | 25 | 0.420 |
Why?
|
| Dentate Gyrus | 1 | 2023 | 37 | 0.400 |
Why?
|
| Professional-Family Relations | 1 | 2024 | 143 | 0.400 |
Why?
|
| Bell Palsy | 1 | 2022 | 7 | 0.390 |
Why?
|
| Facial Paralysis | 1 | 2022 | 22 | 0.380 |
Why?
|
| Lyme Disease | 1 | 2022 | 60 | 0.360 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2024 | 257 | 0.350 |
Why?
|
| Microglia | 1 | 2023 | 251 | 0.340 |
Why?
|
| Brain Injuries | 1 | 2023 | 494 | 0.280 |
Why?
|
| Parents | 1 | 2024 | 1347 | 0.240 |
Why?
|
| Mental Disorders | 1 | 2023 | 1077 | 0.220 |
Why?
|
| Neurons | 5 | 2013 | 1590 | 0.220 |
Why?
|
| Heroin | 1 | 2012 | 31 | 0.190 |
Why?
|
| Narcotics | 1 | 2012 | 52 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2012 | 185 | 0.190 |
Why?
|
| Behavior, Addictive | 1 | 2012 | 81 | 0.190 |
Why?
|
| Cues | 2 | 2012 | 314 | 0.180 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 2607 | 0.150 |
Why?
|
| Cocaine | 2 | 2011 | 166 | 0.140 |
Why?
|
| Fetus | 1 | 2022 | 806 | 0.130 |
Why?
|
| Brain | 3 | 2022 | 2668 | 0.130 |
Why?
|
| Flow Cytometry | 3 | 2012 | 1178 | 0.120 |
Why?
|
| Genes, Immediate-Early | 2 | 2013 | 21 | 0.120 |
Why?
|
| Infant, Newborn | 3 | 2024 | 6079 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2024 | 11074 | 0.110 |
Why?
|
| Intensive Care, Neonatal | 1 | 2024 | 40 | 0.110 |
Why?
|
| Sensation Disorders | 1 | 2024 | 37 | 0.110 |
Why?
|
| Child | 4 | 2024 | 21935 | 0.100 |
Why?
|
| Motor Skills | 1 | 2024 | 97 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 5472 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2024 | 7604 | 0.090 |
Why?
|
| Cell Separation | 1 | 2011 | 318 | 0.080 |
Why?
|
| Fear | 1 | 2013 | 338 | 0.080 |
Why?
|
| Humans | 9 | 2024 | 137585 | 0.080 |
Why?
|
| Adolescent | 3 | 2024 | 21513 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2024 | 1023 | 0.080 |
Why?
|
| Corpus Striatum | 1 | 2011 | 167 | 0.080 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2009 | 59 | 0.080 |
Why?
|
| Infant | 2 | 2024 | 9465 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2012 | 2486 | 0.080 |
Why?
|
| Adaptation, Psychological | 1 | 2024 | 655 | 0.080 |
Why?
|
| Social Determinants of Health | 1 | 2023 | 267 | 0.080 |
Why?
|
| Rats | 5 | 2013 | 5647 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 565 | 0.070 |
Why?
|
| Animals | 7 | 2023 | 36940 | 0.070 |
Why?
|
| Cocaine-Related Disorders | 1 | 2009 | 113 | 0.070 |
Why?
|
| Communication | 1 | 2024 | 879 | 0.070 |
Why?
|
| Female | 6 | 2024 | 73304 | 0.070 |
Why?
|
| Nucleus Accumbens | 1 | 2009 | 138 | 0.070 |
Why?
|
| Hippocampus | 1 | 2023 | 895 | 0.070 |
Why?
|
| Prevalence | 1 | 2024 | 2734 | 0.070 |
Why?
|
| Cognition | 1 | 2024 | 1153 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 2828 | 0.060 |
Why?
|
| Caregivers | 1 | 2024 | 877 | 0.060 |
Why?
|
| Pregnancy | 2 | 2023 | 6763 | 0.060 |
Why?
|
| Male | 5 | 2024 | 67762 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 1083 | 0.060 |
Why?
|
| Neuropeptide Y | 1 | 2012 | 14 | 0.050 |
Why?
|
| Immediate-Early Proteins | 1 | 2012 | 49 | 0.050 |
Why?
|
| Self Administration | 1 | 2012 | 123 | 0.050 |
Why?
|
| Conditioning, Operant | 1 | 2012 | 100 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 5757 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 188 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 431 | 0.050 |
Why?
|
| Extinction, Psychological | 1 | 2012 | 86 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2012 | 231 | 0.040 |
Why?
|
| Head | 1 | 2022 | 105 | 0.040 |
Why?
|
| Rats, Transgenic | 2 | 2011 | 19 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2833 | 0.040 |
Why?
|
| Prefrontal Cortex | 1 | 2012 | 301 | 0.040 |
Why?
|
| Prenatal Care | 1 | 2022 | 294 | 0.040 |
Why?
|
| Mice | 2 | 2023 | 17787 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 596 | 0.040 |
Why?
|
| Young Adult | 1 | 2024 | 13209 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 1738 | 0.030 |
Why?
|
| Aged | 1 | 2024 | 23961 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 15657 | 0.030 |
Why?
|
| Limbic System | 1 | 2013 | 47 | 0.030 |
Why?
|
| Middle Aged | 1 | 2024 | 33479 | 0.020 |
Why?
|
| Reward | 1 | 2013 | 244 | 0.020 |
Why?
|
| Adult | 1 | 2024 | 37929 | 0.020 |
Why?
|
| Dopamine | 1 | 2013 | 303 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 346 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 158 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2009 | 26 | 0.020 |
Why?
|
| Neuropharmacology | 1 | 2009 | 5 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2009 | 29 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 767 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 976 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1316 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 2009 | 290 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2009 | 309 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2009 | 501 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 1502 | 0.020 |
Why?
|
| Learning | 1 | 2009 | 409 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 1864 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 4295 | 0.010 |
Why?
|